Comments about the Edwards Life Sciences SAPIEN Transcatheter Heart Valve | Which Medical Device
Categorised under:
Cardio-thoracic
>
Non-coronary intervention
>
Aortic Valves
Did you know you can Register for FREE with this website?
Registration gives you full access to all of the features of WhichMedicalDevice. Find out more ...
WhichMedicalDevice is a FREE resource created by clinicians for clinicians.
Registration is free and gives you unlimited access to all of the content and features of this website.
Find out more...Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...
Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.
We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.
Comments
Comment by douglasmuir Commented Jun 11, 2013
Impact factor: 50
With the newer iterations, the device is now much lower profile and sheath size has reduced (16F, 18F and 20F for 23mm, 26mm and 29mm Sapien XT respectively). In our institution, this has meant that around 80% of patients are suitable for a transfemoral approach.
Whilst no comparative randomised data exists regarding optimal access route, it is widely held that TF access is associated with shorter recovery times and is the least \"invasive\" of the available options.
As the device range spans annulus sizes from 18-27.5mm and access is possible through transfemoral, transapical and trans-aortic routes, there are very few patients who now have a technical contra-indication to TAVI with the Sapien XT system.
Comment by Commented Feb 5, 2013
User Rating
This comment has been added by the Associate Editor at whichmedicaldevice.
The SAPIEN Transcatheter Heart Valve was the runner-up in the cardiology category of Which Medical Device of the Year 2012.
Our nominator said, "A disruptive technology that will change the treatment of aortic valvular disease" and "Not only did the SAPIEN valve has provided a treatment alternative to thousands of patients in 'aortic stenosis death-row' who had no other option, but it did so in an extremely responsible way. The US launch of this device has been conducted in the most rigorous way to ensure patient safety and outstanding outcomes.”
"Edwards valve won 2 years ago and wassa runner up last year"..."Great product"... "Proven to add life to years and years to life.”